Botulinum toxin for the treatment of secretory disorders of the head and neck area

被引:1
作者
Steffen, A. [1 ]
机构
[1] Univ Lubeck, Univ Klinikum Schleswig Holstein, Klin Hals Nasen & Ohrenheilkunde, D-23538 Lubeck, Germany
关键词
Hypersalivation; Frey's syndrome; Rhinitis; Gustatory tearing; Botulinum toxin; CROCODILE TEARS; INJECTION; HYPERLACRIMATION; MANAGEMENT; GLAND; RHINOSINUSITIS; SECONDARY; PALSY;
D O I
10.1007/s00106-012-2498-x
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Botulinum toxin can be used for the temporary blockade of secretory glands in the head and neck area. Botulinum toxin is increasingly the therapy of choice for the treatment of Frey's syndrome and gustatory tearing, and it is gaining attention for hypersalivation therapy. For nasal hypersecretion, this drug has a very specific use. In comparison to the treatment of skeletal muscles, the individual effect and its duration are more difficult to predict. All indications presented here are for off-label use; therefore, careful counseling and informed consent are necessary. With botulinum toxin, for several diseases, as new treatment options are opening up, well-founded knowledge about the indications and treatment course is important for the ENT surgeon.
引用
收藏
页码:484 / 489
页数:6
相关论文
共 29 条
[1]   Long term efficacy and safety of botulinum toxin A injection for crocodile tears syndrome [J].
Barañano, DE ;
Miller, NR .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2004, 88 (04) :588-589
[2]   Quality of life in patients with chronic rhinosinusitis. Validation of the Sino-Nasal Outcome Test-20 German Adapted Version [J].
Baumann I. ;
Blumenstock G. ;
DeMaddalena H. ;
Piccirillo J.F. ;
Plinkert P.K. .
HNO, 2007, 55 (1) :42-47
[3]   Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy [J].
Boroojerdi, B ;
Ferbert, A ;
Schwarz, M ;
Herath, H ;
Noth, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 65 (01) :111-114
[4]   A review of the surgical and medical treatment of Frey syndrome [J].
Clayman, Mark A. ;
Clayman, Scott M. ;
Seagle, M. Brent .
ANNALS OF PLASTIC SURGERY, 2006, 57 (05) :581-584
[5]   SUBMANDIBULAR DUCT RELOCATION FOR DROOLING - A 10-YEAR EXPERIENCE WITH 194 PATIENTS [J].
CRYSDALE, WS ;
WHITE, A .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1989, 101 (01) :87-92
[6]  
Drobik C, 1994, HNO AKTUELL, V2, P142
[7]   Successful management of drooling with botulinum toxin A in neurologically disabled children [J].
Ellies, M ;
Rohrbach-Volland, S ;
Arglebe, C ;
Wilken, B ;
Laskawi, R ;
Hanefeld, F .
NEUROPEDIATRICS, 2002, 33 (06) :327-330
[8]   Injection of botulinum toxin type B for the treatment of otolaryngology patients with secondary treatment failure of botulinum toxin type A [J].
Guntinas-Lichius, O .
LARYNGOSCOPE, 2003, 113 (04) :743-745
[9]   Increased botulinum toxin type a dosage is more effective in patients with Frey's syndrome [J].
Guntinas-Lichius, O .
LARYNGOSCOPE, 2002, 112 (04) :746-749
[10]   Risk of facial palsy and severe Frey's syndrome after conservative parotidectomy for benign disease: analysis of 610 operations [J].
Guntinas-Lichius, Orlando ;
Gabriel, Bettina ;
Klussmann, J. Peter .
ACTA OTO-LARYNGOLOGICA, 2006, 126 (10) :1104-1109